Verve Therapeutics, Inc.

This clinical-stage genetic medicine company is focused on the development of therapies for cardiovascular diseases. With a commitment to pioneering a new era of care, it leverages gene editing and gene therapy technologies to create transformative treatments. The company's innovative approach aims to provide long-lasting benefits to patients with serious heart conditions.